Skip to main content
Log in

A simple, reproducible animal model of arterial occlusion with mixed thrombus

  • Basic Research
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Background: Current animal models of thrombotic arterial occlusion are complex and difficult to perform. A more simplified model of thrombotic occlusion with angiographic endpoints and mixed thrombotic composition would be useful to assess the effectiveness of new therapeutic modalities. Methods and results: Femoral arteries in 38 New Zealand White rabbits were cannulated. The animal protocol involved denudation of one iliac artery by stripping with progressively increasing balloon size, followed by inflow arterial occlusion and the addition of thrombin. Cineangiography was performed at baseline and 10 minutes after the procedure to assess TIMI blood flow. Baseline angiography revealed normal TIMI 3 flow in all arteries. A successful angiographic endpoint of TIMI 0 or TIMI 1 blood flow was achieved in only 6 or 46% of 13 rabbits with initial use of the protocol, but was successful in 25 or 100% of a consecutive series of rabbits after the initial or repeat use of the protocol. Importantly, histologic analysis of thrombus revealed a mixture of platelets, erythrocytes, and fibrin. The mean injury index of the internal elastic lamina (IEL) was 40.7 ± 35.16%. No correlation was found between TIMI flow change and intact IEL (R = \s-0.068, p > 0.5). Total procedure time was about 1 hour. Conclusion: This simple and reproducible animal model of arterial occlusion provided a mixed thrombus that is comparable to human thrombus and thus may be useful to assess thrombolytic agents or new coronary interventional devices.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Shebuski RJ, Storer BL, Fujita T. Effect of thromboxane synthetase inhibition on the thrombolytic action of tissue-type plasminogen activator in a rabbit model of peripheral arterial thrombosis. Thromb Res 1988;52:381–392.

    Google Scholar 

  2. Gold HK, Yasuda T, Jang IK, Gorier J, Fallon JT, Leinbach RC, Collen D. Animal models for arterial thrombolysis and prevention of reocclusion. Erythrocyte-rich versus plateletrich thrombus. Circulation 1991;83(Suppl IV):IV26-IV40.

    Google Scholar 

  3. Blair E, Nygren E, Cowley RA. A spiral wire technique for producing gradually occlusive coronary thrombosis. J Thorac Cardiovasc Surg 1964;48:476–485.

    Google Scholar 

  4. Salazar AR. Experimental myocardial infarction, induction of coronary thrombosis in the intact closed-chest dog. Circ Res 1961;9:1351–1356.

    Google Scholar 

  5. Runge MS, Haber E. Importance of experimental models in study of thrombosis and thrombolysis. Circulation 1991;83(Suppl IV):IV1-IV79.

    Google Scholar 

  6. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial.N Engl J Med 1985;312:932–936.

    Google Scholar 

  7. Friendman MF, Van der Bovenkamp GJ. The pathogenesis of a coronary thrombus. Am J Pathol 1964;48:19–44.

    Google Scholar 

  8. Grines LC. Thrombolytic, antiplatelet and antithrombotic agents. Am J Cardiol 1992;70:18I-26I.

    Google Scholar 

  9. Becker R. Recombinant t-PA and platelet activity. Cleve Clin J Med 1990;57:537–541.

    Google Scholar 

  10. Falk E. Coronary thrombosis: Pathogenesis and clinical manifestations. Am J Cardiol 1991;68:28B-35B.

    Google Scholar 

  11. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: Clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926–935.

    Google Scholar 

  12. Mehra A, Faxon DP. Current status of percutaneous transluminal coronary angioplasty. Curr Probl Cardiol 1994;19:231–283.

    Google Scholar 

  13. Ross R. Rous-Whipple Award Lecture. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 1993;143:987–1002.

    Google Scholar 

  14. Jang IK, Gold HK, Ziskind AA, et al. Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator: A possible explanation for resistance to coronary thrombolysis. Circulation 1989;79:920–928.

    Google Scholar 

  15. Masayuki K, Fujiwaya H, Kawamura A, Htay T, Yoshikuni Y, Mori K, Sasayama S. An animal model of coronary thrombosis and thrombolysis. Jpn Circ J 1993;57:1000–1006.

    Google Scholar 

  16. Bush LR, Shebuski RJ. In vivo models of arterial thrombosis and thrombolysis. FASEB J 1990;4:3087–3098.

    Google Scholar 

  17. Rentrop KP. Thrombolytic therapy in patients with acute myocardial infarction. Circulation 1985;71:627–631.

    Google Scholar 

  18. Topol EJ, Califf RM, George BS, et al. Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in acute myocardial infarction. Circulation 1988;77:1100–1107.

    Google Scholar 

  19. Loscalzo J, Vaughan DE. Tissue plasminogen activator promotes platelet disaggregation in plasma. J Clin Invest 1987;79:1749–1755.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, S., Garner, D.J., Romano, M. et al. A simple, reproducible animal model of arterial occlusion with mixed thrombus. J Thromb Thrombol 3, 337–341 (1996). https://doi.org/10.1007/BF00133077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00133077

Key Words

Navigation